Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

FDA Approval Author: FDA Consumer Health Information Last Updated: Nov 29, 2012 - 7:11:02 AM



FDA Expands Caution About SimplyThick

By FDA Consumer Health Information
Sep 18, 2012 - 11:31:31 AM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page
(HealthNewsDigest.com) - FDA wants parents, caregivers and health care professionals to be aware that infants of any age may face an increased risk of developing a life-threatening condition if fed a thickening product called SimplyThick.

The agency has identified 22 infants who developed necrotizing enterocolitis (NEC), a condition in which tissue in the intestines becomes inflamed and dies, after being fed SimplyThick. Seven of those infants have died. FDA had issued an advisory in May 2011 that warned of the risk to infants born prematurely. Now, FDA is extending that advice to include infants on any age.

SimplyThick is a brand of thickening agent—available to consumers and medical centers—to help manage swallowing difficulties.

###

For advertising and promotion on HealthNewsDigest.com please contact Mike McCurdy: [email protected] or 877-634-9180
HealthNewsDigest.com is syndicated worldwide, to thousands of journalists in all media, and health-related websites. www.HealthNewsDigest.com

Top of Page

HealthNewsDigest.com

FDA Approval
Latest Headlines


+ FDA Approves Zydelig for Three Types of Blood Cancers
+ Alere Receives FDA Clearance for Alere™ i Influenza A and B Test First-ever Platform to Deliver Highly Accurate, Molecular Results in Under 15 Minutes
+ BioDelivery Sciences Receives FDA Approval for BUNAVAIL(TM) (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence
+ GenomeTrakr Helps FDA Identify Dangerous Bacteria
+ FDA Approves First Generic Versions of Celecoxib
+ FDA Allows Marketing of First Non-invasive Test to Help in Identifying Cause of Certain Kidney Disease
+ Trimel Receives FDA Approval for Natesto™ Nasal Gel to Treat Men with Low Testosterone
+ Harnessing the Power of Databases to Evaluate Medical Products
+ FDA Approves Drug-Free Treatment CEFALY® for Migraine Prevention
+ FDA Opens Review of Rules for Over-the-Counter Drugs, Including Acetaminophen



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions